Welcome to Sydney, Australia! Sydney is one of the world’s most picturesque cities that is surrounded by a majestic harbour and scattered with beaches, national parks and iconic buildings. It is a city that is inviting you to explore. Catch a ferry across the harbour to take in a panoramic view of the iconic Sydney Harbour Bridge and Sydney Opera House, cuddle up to a cute Koala at Taronga Zoo Sydney or discover the city from above at the Sydney Eye Tower.
Dr. Gardner is a dermatopathologist and section head of bone/soft tissue pathology at Geisinger Medical Center in Danville, Pennsylvania. He was formerly an Associate Professor of Pathology and Dermatology and dermatopathology fellowship program director at the University of Arkansas for Medical Sciences (UAMS). He obtained his MD from Tulane University in New Orleans, completed residency in anatomic and clinical pathology at Houston Methodist Hospital, and completed fellowships in bone/soft tissue pathology and dermatopathology at Emory University in Atlanta. Dr. Gardner has over 110 peer-reviewed publications as well as multiple book chapters. He is also author of the book Survival Guide to Dermatopathology and co-author of the book Survival Guide to Soft Tissue Pathology. He is particularly interested in cutaneous soft tissue tumors, skin adnexal tumors, medical education, and the professional use of Twitter, Facebook, YouTube, and other social media for pathologists. He is an active volunteer member in a variety of sarcoma and other rare disease patient support groups on Facebook. He has used his relationship with these patient groups to conduct formal medical research and to advocate on behalf of their diseases (info: https://youtu.be/tW7dzU0Gg34). His work has been recognized by multiple awards, including the UAMS Chancellor’s Teaching Award for Teaching Excellence (2018), which is the University’s highest educational award. He was also a top five member of the 2017 “40 Under Forty” by the American Society of Clinical Pathology and was ranked first place on the 2019 Power List of pathology trailblazers issued by The Pathologist magazine. He is a Deputy Editor-in-Chief of Archives of Pathology & Laboratory Medicine.
Dr Tristan Rutland graduated from the University of Wollongong with distinction in 2011. In 2020, he was the recipient of the Konrad Muller RCPA Outstanding Teaching Award. He has experience in teaching all levels of medical training from 1st year medical students to final year pathology registrars and involved in cross speciality training of registrars including dermatology, surgical and oncology registrars. One of this passions is teaching through social media, in particular, Twitter, where he is internationally recognised as a medical educator.
As well as teaching all levels of medical students, he also runs the master of medicine (pathology), which is an entirely online course. He has also implemented virtual pathology, which acts as a lynch pin to pathology teaching at WSU.
Currently based at Western Sydney University and Liverpool hospital as an anatomical pathologist, he has a sub-speciality interest in gastrointestinal pathology.
He sits on the RCPA academic committee and is co-chair of social media for the Australasia division of the international academy of pathology.
Dr. Trpkov is an internationally recognized expert in uropathology. He is one of the leading Canadian uropathologists and he is a consultant for the Calgary Laboratory Services, Southern Alberta Institute of Urology and the Tom Baker Cancer Center in Calgary, Canada. He is also a Genitourinary (GU) Pathology Group Leader for the Calgary Laboratory Services, Chair of the provincial GU pathology Special Interest Group and a member of the provincial GU cancer team for the province of Alberta, Canada.
Dr. Trpkov has published more than 100 peer-reviewed articles, several book chapters and other scholarly contributions. Dr. Trpkov is passionate about teaching and has conducted numerous courses, workshops and slide seminars in uropathology. He as been invited to speak on all continents. He is involved as a uropathology expert with several national and international expert panels and organziations, which establish guidelines in uropathology and prostate cancer. Dr. Trpkov has received several awards for his work. In 2013, he has been awarded the Grawitz medal for his outstanding contributions to the International Society of Urologic Pathology (ISUP).
Dr Francesca D'Souza graduated from the University of Sydney in 2002, following completion of a Bachelor of Science degree at the University of Western Australia. She conducted her training in anatomical pathology at Westmead Hospital, where she gained experience in teaching and conference presentations, as well as journal publications. Dr D'Souza's training included rotations to Douglass Hanly Moir Pathology, BreastScreen NSW, Nepean Hospital and Forensic Medicine. She completed her training and postgraduate studies in 2011. She has special interests in urological, gastrointestinal and cytopathology.
Dr. Surya Seshan is a nationally recognized expert in renal pathology. Dr. Seshan received medical training in her native India and completed pathology residency at New York Medical College. She trained in renal pathology with the legendary Dr. Jacob Churg, remained his associate for many years, and then became Director of Laboratories at Barnert Hospital in Paterson, New Jersey. Dr. Seshan joined Weill Cornell Medicine in January, 2000 as Chief of Renal Pathology.
Dr. Seshan has contributed numerous scientific articles to the literature and has co-authored three textbooks: The Kidney in Collagen Vascular Diseases, Classification and Atlas of Glomerular Diseases, and Renal Disease: Classification and Atlas of Tubulointerstitial and Vascular Diseases of the Kidney. Dr. Seshan directs a large renal pathology consultation practice, serving as the renal pathologist for several institutions in the tri-state region. The Renal Pathology Laboratory is equipped to handle all aspects of the renal biopsy from the moment it is obtained from the patient, including light microscopy, immunofluorescence, and electron microscopy. Dr. Seshan is available to provide personal consultation in all areas of renal pathology.
Dr Jingjing Li is a Senior Postdoctoral Fellow at the Graduate School of Biomedical Engineering. She is working with A/Prof Robert Nordon on a CRC-P project developing an automated microscale bioreactor for cell and gene therapy.
Being trained as a biomedical engineer, she developed multidiscipline skills spans from microfluidics, developmental biology, and bioinformatics. Her PhD and Post-Doctoral research focus on studying the influence of pulsatile fluid shear stress on human embryonic blood formation using microfluidic model mimicking foetal circulation, live cell imaging of hPSC differentiation and single-cell RNA sequencing of developing blood niches.
Her research interests are developing microfluidic organ-on-a-chip models and their applications in the expansion, maturation and engraftment of blood stem and progenitor cells generated from human pluripotent stem cells (hPSCs) for clinical therapies.
Dr Esther Myint graduated, in 1979, from the Institute of Medicine 1, Rangoon, Burma, and received her qualifications in general pathology, in 1985, from the same institute. She won a scholarship from WHO to study for her MSc in immunology at the University of Birmingham, UK, awarded in 1992. Dr Myint was retrained in anatomical pathology at John Hunter Hospital, Newcastle, and the Royal Prince Alfred Hospital, Sydney, and received her FRCPA Fellowship in 2011. She has considerable undergraduate and postgraduate teaching experience and is currently an Adjunct Lecturer at the University of Western Sydney and a Senior Lecturer at The University of Notre Dame. Dr Myint is also Co-Chief Examiner for the Anatomical Pathology division of the Royal College of Pathologists of Australasia (RCPA) , and commits herself to the education programs of pathology by the RCPA, instigating courses for anatomical pathology registrars, including ‘Milestones in Pathology’ and ‘Yardsticks in Pathology’. Currently, she is a convenor for the new ‘Cutting Edge Pathology’ conference for reporting pathologists. Dr Myint is a member of the overseas-trained specialist assessment committee and is also on the advisory committee for the quality assurance program of the RCPA – Quality Assessment Program. She joined Douglass Hanly Moir Pathology in May 2014.
Dr. Stephen Raab is a pathologist in Jackson, Mississippi and is affiliated with University of Mississippi Medical Center. He received his medical degree from State University of New York Upstate Medical University and has been in practice for more than 20 years.
Dr. Stephen Raab has joined the Faculty of Medicine as professor of laboratory medicine, also serving as clinical chief of laboratory medicine with Eastern Health. He is also an adjunct professor of pathology with the University of Washington. Dr. Raab comes to Memorial from Denver, Colorado where he worked with the Colorado Health Outcomes Program. He served as the director of anatomic pathology with the Department of Pathology at the University of Colorado from 2008-2010. He has also worked at the University of Pittsburgh, the University of Iowa Hospitals and Clinics and as an advisor to the Pathology Department at the Ho Chi Minh City Cancer Hospital in Viet Nam.
Dr King Tan graduated from the University of New South Wales with First Class Honours in 2004. He obtained Fellowship of the Royal College of Pathologists of Australasia in 2011, with training rotations at Southern.IML Pathology, Concord Hospital, Douglass Hanly Moir Pathology, Royal Prince Alfred Hospital, Department of Forensic Medicine in Glebe and The Children’s Hospital at Westmead. Dr Tan subsequently completed a lymphoma pathology research fellowship with Professor Randy Gascoyne at the Centre for Lymphoid Cancer, British Columbia Cancer Agency in Vancouver, and has publications in this field. He was Staff Specialist at Westmead Hospital from 2012 to 2020, where he continued his interest in haematolymphoid pathology, and also developed interests in neuropathology, lung and gynaecological pathology. Dr Tan is enthusiastic about teaching, and is a Clinical Senior Lecturer with the University of Sydney. He joined Douglass Hanly Moir Pathology in February 2020.
Dr Edwina Duhig is one of Australia's leading pulmonary histopathologists with extensive experience in nonneoplastic and neoplastic pulmonary diseases and diseases of pleura. She is the author of four sections (primary germ cell tumours, primary meningioma, primary thymoma and primary melanoma) on ectopic tumours of the lung in the forthcoming WHO classification of lung tumours. She is widely published on pulmonary and cardiac diseases.
She has recently been a member of the expert pathology panel for lung adenocarcinomas as part of The Cancer Genome Atlas Network and was a co-author of the paper by this group that details comprehensive molecular profiling of adenocarcinoma.
Dr Duhig graduated from The University of Queensland in 1989 followed by a residency at The Royal Brisbane Hospital. She undertook her pathology training at the Greenslopes Repatriation Hospital and The RBH, with rotations to Prince Charles Hospital and the Institute of Forensic Pathology. Following the completion of her RCPA fellowship, she became a staff specialist at the Prince Charles Hospital and in 2007 became director of the department of anatomical pathology. In 2011 she became acting director of the Prince Charles Laboratory Group for Pathology Queensland and fulfilled this role until her departure to take up a role with Sullivan Nicolaides Pathology, Tugun Laboratory. She is actively involved in maintaining professional standards.
Dr. Henry Tazelaar is Chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic in Arizona, and he is a Consultant in the Division of Anatomic Pathology in Arizona. Dr. Tazelaar also serves as Chair of the Laboratory Medicine and Pathology Specialty Council. He joined the staff of Mayo Clinic in 1988 and holds the academic rank of Professor of Laboratory Medicine and Pathology.
Dr. Tazelaar earned his Bachelor of Arts degree at Calvin College in Grand Rapids, Michigan, and his M.D. at Rush Medical College in Chicago. He completed both an internship and residency in pathology at Stanford University Medical Center, followed by a National Institutes of Health postdoctoral fellowship in the pathology of heart-lung transplantation in the laboratory of Dr Margaret Billingham at Stanford University Medical Center, where he subsequently completed a fellowship in surgical pathology. Dr. Tazelaar’s work has focused on refining criteria used to diagnose the rejection of transplanted hearts and lungs. He is also active in identifying new pulmonary diseases and better understanding how systemic diseases affect the lungs and pleura. His observations have led to the identification of several new or unusual pulmonary diseases.
A/Prof Sonja Klebe is a senior staff specialist in Diagnostic Pathology at Flinders Medical Centre and a Clinical Academic Associate Professor at Flinders University. She has a special interest in pleuropulmonary pathology and molecular pathology with a focus on mesothelioma and asbestos-related diseases.
Sonja graduated from Medicine at the Free University of Berlin, with a MD in Biochemistry. She completed a PhD in Immunology and Gene Therapy at Flinders University in Adelaide in 2000 and obtained her Fellowship from the Royal Australasian College of Pathologists (RCPA) in 2005.
She is a Member of the International Mesothelioma Panel, the Pulmonary Pathology Society and the International Mesothelioma Interest Group (IMIG) and IASLC staging committee. She is also a member of Lung Expert Group for development of Lung Cancer Structured Reporting Protocol for the RCPA and heads the mesothelioma structured reporting. She is a contributor to the WHO blue books. She regularly serves as an expert on diagnosis in mesothelioma to the courts. She has been an invited speaker for the Australian Society of Cytology Annual Conference, the Australian Lung Cancer Conference, World Lung Cancer Conference and the Australasian Pleuropulmonary Society as well as COSA.
She has successfully supervised 7 honours and 6 PhD students to completion. Her interests have focussed on clinically relevant basic research applications, and her 7-year appointment as Chief Examiner for the RCPA underscores her standing as an expert in pathological processes. She has published 5 book chapters and over 100 peer-reviewed publications.
My name is Mike Watson, I'm a histopathologist, and my interest is paediatric pathology. My usual working day runs from about 0830 to 1730, and my time is divided between the cut up room where the specimens are handled, and the microscope. In a typical day I will spend some time in cut up, supervising registrars dissecting specimens, doing so myself, and selecting tissue for frozen section. Most of my time is spent at the microscope reporting histology, and teaching registrars. I thought it easiest to illustrate typical activities in my day with a couple of examples.
After finishing all seven of her postdoctoral training programs, Dr. Chévez-Barrios joined the faculty of the Baylor College of Medicine in 1996 as an Assistant Professor in the Department of Pathology, with a secondary appointment in the Department of Ophthalmology. She became a Clinical Assistant Professor in the Department of Ophthalmology there in 2004, and received the Fulbright & Jaworski LLP Award for Faculty Excellence in Teaching and Evaluation and became Associate Member of the Cell and Gene Therapy Center that same year. She has current appointments of adjunct professor in the Department of Pathology at The University of Texas MD Anderson Cancer Center and Department of Ophthalmology at the Baylor College of Medicine. Dr. Chévez- Barrios assumed her current positions at Methodist in 2004.
The main research interest of Dr. Chévez-Barrios and her laboratory is the study of retinoblastoma, including cancer stem cells, suicide gene therapy for retinoblastoma, the study of metastatic properties of retinoblastoma and preclinical models of the tumor. Other topics of interest are ocular gene therapy, cataractogenesis, vascular proliferation in hypoxic ocular diseases and corneal diseases. Dr. Chevez-Barrios’ laboratory is currently participating in the project of gene therapy for Retinoblastomas in collaboration with the Texas Children’s Cancer Center and the Center for Gene Therapy of Texas Children's Hospital, and Baylor College of Medicine. Pre-clinical studies and a phase 1 clinical trial of vitreous seed of retinoblastoma have been completed. The phase II clinical trial is in preparation. Dr. Chevez-Barrios is a committee member responsible of evaluating all enucleated eyes from the prospective multicenter study of the ARET0332 Children’s Oncology Group protocol on “A Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy. Dr. Chevez-Barrios is also interested in the biological differences between retinoblastoma cell lines that have the capability of producing metastasis, and those that behave less aggressively and remain as intraocular tumors.
Dr Juan Ortiz is a general histopathologist. He completed his medical training in Colombia before moving to Australia, where he undertook specialty training in anatomical pathology in Brisbane. He obtained the Royal College of Pathologists of Australasia Fellowship in 2013 and worked in private practice before undertaking a clinical fellowship in ophthalmic pathology at the Houston Methodist Hospital, USA. Dr Ortiz returned to Australia and joined Sullivan Nicolaides Pathology, where he gained further experience in dermatopathology and general pathology. He joined Douglass Hanly Moir Pathology in 2019 and is strongly committed to the delivery of high quality pathology services, as well as taking an active role in the local community.
Prof Christopher Corless has expertise in molecular pathology, particularly in oncology-related applications, including test development and validation. As chief medical officer for an academically-based molecular diagnostics laboratory, Professor Corless has experience in laboratory management and have served as a consultant to a number of companies, including Novartis, Pfizer, Roche/Genentech, Roche/Ventana, Asuragen, Cepheid, Leica Biosystems and ThermoFisher. Christopher also has over 20 years of experience as a staff pathologist in academic practice, with a particular interest in GI and GU pathology
Specialties: Next-generation sequencing; real-time quantitative PCR; immunohistochemistry; Nanostring GeoMx DSP platform
Dr. Paul Waring is an anatomical, molecular and translational pathologist who is a pioneer in the application of molecular and genomic technologies to cancer diagnostics and cancer drug development. Dr. Waring served in various senior academic and industry positions including Director of Pathology at the Peter MacCallum Cancer Centre in Melbourne Australia, Senior Director of Pathology and Diagnostics at Genentech, USA, Chair of Pathology at the University of Melbourne, and Vice President of Medical Innovation at Roche Diagnostics USA. He has published over 140 scientific articles and abstracts, and served on numerous committees and advisory boards in the fields of cancer molecular pathology and personalized medicine. He earned an MBBS degree from the University of Western Australia, completed anatomic pathology training at the Queen Elizabeth II Medical Centre in Western Australia and a PhD in Cancer Biology from the Walter and Eliza Hall Institute at the University of Melbourne.
Professor Anja C. Roden, M.D., studies mediastinal neoplasms such as thymic epithelial tumors and primary mediastinal germ cell tumors from morphologic, immunophenotypical, molecular and clinical aspects. She developed and maintains a database that now includes over 600 patients with these rare tumors. This database forms the foundation of many of her studies.
Dr. Roden is also researching lung tumors, specifically neuroendocrine and salivary gland-type tumors, malignant mesotheliomas, and nonneoplastic lung diseases including interstitial lung diseases and lung allografts. She developed and maintains a large database of lung allograft biopsies. In addition, she actively participates in multidisciplinary global studies of mediastinal neoplasms and multi-institutional studies of malignant mesotheliomas and lung tumors.
Focus Areas
Dr Tina Baillie graduated from the University of Witwatersrand, Johannesburg, South Africa and then moved to Auckland, New Zealand, where she specialised in histopathology and cytopathology. After attaining her Fellowship of the Royal College of Pathologists of Australasia in 2001, she worked as Staff Specialist at Auckland Hospital for five years. After Dr Baillie and her family relocated to Sydney, she joined Douglass Hanly Moir Pathology, in October 2006. She has a wide range of interests including pulmonary, head and neck and endocrine pathology and is currently a Senior Lecturer at the School of Medicine, University of Notre Dame.
Professor Sanjay Kakar, MD, is professor of pathology, Chief of the GI-liver pathology service, and GI-liver pathology fellowship director at University of California San Francisco. After completing medical school training in India, he attended the University of Illinois in Chicago for pathology residency followed by GI-liver and molecular pathology fellowships at Mayo Clinic, Rochester, MN. He is past president of United States Gastrointestinal Pathology Society, has served on the CAP Surgical Pathology Committee and is currently a member of the CAP Cancer Committee and AJCC staging panel for colorectal and hepatobiliary cancers. His principal research interests are focused on hepatocellular adenoma, hepatocellular carcinoma and colorectal cancer.
Dr Greg Miller is a medical graduate of the University of Queensland and a Fellow of the Royal College of Pathologists of Australasia. Dr Miller joined Envoi in 2014 and completed a two year Fellowship in Gastrointestinal and Liver Pathology. He has presented at national meetings on gastrointestinal pathology. His research interests focus on both liver-related basic research and clinical gastrointestinal pathology.
Dr Edwin Tan graduated from the University of Adelaide in 2008. Following graduation, Edwin rotated through a broad range of clinical specialties. In 2013, Edwin moved to Brisbane and commenced training in anatomical pathology. He was awarded his FRCPA in 2018 and worked at the Townsville University Hospital reporting a broad range of pathology which included pathology of tropical diseases. He subsequently joined IQ Pathology to subspecialise in dermatopathology with an interest in ocular, haematolymphoid and soft tissue pathology.
Dr Rory Donnellan is the grandson of a renowned Surgeon/Pathologist, Dr Basil Sampson, who worked at Guy’s Hospital, London, England before moving to KwaZulu-Natal in South Africa. Apart from his interest in surgical pathology, Dr. Basil Sampson also distinguished himself in safely delivering many of the local Zulu chief's children throughout the Ixopo district, where he inherited a lush, dairy farm at a place called Hlutankungu (a Zulu word which means place in the heavens).
Dr. Rory Donnellan still has his grandfather’s old Zeiss microscope and also carries his grandfather’s name – Dr Donnellan’s second name is Basil.
Dr Donnellan graduated from the University of Cape Town Medical School in 1994, and very soon realised his affinity for pathology. He became a member of the South African College of Pathologists in 1999, and a fellow of the Royal College of Pathologists, London, England in 2001, before being lured to Dr Bouwer and Partners in Durban for 3 years. After marrying a beautiful American nurse, he undertook a fellowship in neuropathology in Seattle, Washington, USA from 2003 to 2004.
Dr Donnellan was a staff pathologist at Mater Pathology in Brisbane from 2004 to 2007, and then went to Bundaberg for 3 years with one of the big corporate pathology groups. In 2010, he took the bold step of starting Immaculata Pathology with the aim of ensuring local diagnostic services would continue to flourish in regional and rural areas of Queensland even as the big corporate behemoths began consolidating their services in metropolitan ivory towers. He enjoys communicating with referring doctors and hearing their interesting clinical perspectives.
Dr Touraj Taheri is a full-time senior consultant anatomical pathologist at the Royal Brisbane and women’s Hospital since 2011 which is known to be one of the largest tertiary referral Hospital in head and Neck surgery in Australasia. Having been trained in Royal Brisbane Hospital and Mater Hospital, he completed his fellowship from The Royal college of pathologists of Australia in Anatomical pathology and cytopathology (2010). Touraj is member of head and neck cancer clinic for the past 10 years and is the lead head and neck pathologist at central lab, pathology Queensland, completing numerous consultation cases for review and diagnosis from other pathology departments in Queensland. He is enthusiastic about teaching delivered to pathology and surgical registrars and holds an appointment as a senior lecturer at the University of Queensland. He has been involved in multiple research projects and publications in ENT cancer and pathology.
I am an anatomical/surgical pathologist currently working in the public health system. However, I have also worked in private pathology for many years. As such, I have gained both public and private pathology experience in Australia. In addition, I was the head of department for the Anatomical Pathology department in Healthscope pathology for a year before moving on to be a full time public pathologist to pursue further research and academic opportunities. I am also involved in various committees within the Royal College of Pathologists of Australasia such as NSW state committee member, anatomical pathology advisory committee member and also an examiner for the anatomical pathology discipline. My goals are to provide the best diagnostic pathology service within the hospital department by integrating the best of my private pathology experience with the public health sector. In addition, I am continually involved with research projects and teaching commitments with the hospital, college and Sydney University. At the same time, my involvement in various committees of the Royal College of Pathologists of Australasia allows me to serve the fellows of the college in a more global capacity.
Professor Laurence de Leval obtained her MD degree in July 1994 at the University of Liège Summa cum laude. In 1998 she earned a PhD in Biomedical Sciences at the University of Liège. She passed The United States Medical Licensing Examination in 1999 and became Board certified in Pathologic Anatomy and Cytology in 2000. In 2007 she earned the Agrégation de l’Enseignement Supérieur at the University of Liège.
Her research training included a Research Fellowship of the Belgian National Fund for Scientific Research (FNRS) from 1994-1998 and between 1998-1999 a post-fellowship in Hematopathology at Harvard medical
School, Boston. From 2000-2002 she was staff member, Department of Pathology, CHU Sart Tilman and from 2002-2006 Associate Laboratory Director, Department of Pathology, CHU Sart Tilman and since2006 Director.
In 2007 she became Permanent Research Associate of the FNRS, in 2008 Clinical Professor of Pathology, University of Liège and in 2009 Professeur Ordinaire and chef de service of clinical pathology at CHUV, Lausanne.
A graduate of University of Queensland, St. Lucia, Penny began her anatomical pathology training at Royal Brisbane Hospital in 1983. In September 1985, she continued her training at L'Hôpital Necker-Enfants Malades in Paris for over a year. Her final year of training was at Royal Children's Hospital in Melbourne after a brief period in Haematology at Royal Brisbane Hospital in late 1986. After obtaining her final qualifications in Anatomical Pathology in February 1988, she worked as a lecturer in Pathology at University of Melbourne, with Dr. Ross Anderson as mentor in neuropathology.
In mid 1990, Penny commenced a neuropathology fellowship at Boston Children's and Brigham and Women's Hospitals in Boston and instructor in Pathology at Harvard Medical School. In September 1992, Penny commenced at St. Vincent's Hospital as Staff Neuropathologist.
Apart from neuropathology, Penny has been in charge of the hospital autopsy service since 1995 and has been the pathologist reporting the ocular pathology from the Royal Victorian Eye and Ear Hospital. Due to this interest in ocular pathology, she has been a regular tutor to the ophthalmology registrars and since 1996, an examiner for the Royal Australian and NZ College of Ophthalmologists. Penny became Associate Professor of Pathology at University of Melbourne in 2002.
Gynaecological perinatal and breast pathology cytopathology Medical Director, Director of Anatomical Pathology A/Prof Kerryn Ireland-Jenkin Email: kerryn.ireland-jenkin@austin.org.au Phone: 9496-5285 B12 Testing and Troponin Alert: New Memos for Clinicians available here Gynaecological, perinatal and breast pathology, cytopathology Kerryn obtained a Bachelor of Medicine and Surgery from the University of Melbourne, and trained as an Anatomical Pathologist, obtaining Fellowship in 2000. She completed a twelve-month Fellowship in cytopathology at the Victorian Cytology Service (VCS) in 2001, before working at Melbourne Pathology. Kerryn joined Austin Pathology in 2006 with a primary focus on pathology in women’s health. She has expertise in gynaecologic and perinatal pathology, breast pathology and cytopathology and has key roles in multidisciplinary meetings in breast pathology, gynaecologic oncology (at Mercy Hospital for Women) and respiratory pathology. Kerryn is a Clinical Associate Professor in the Department of Pathology at University of Melbourne and is the Treasurer of the Australian Society for Colposcopy and Cervical Pathology. She is a member of the RCPA Expert Committee for Gynaecological Cancers, and has co-authored RCPA cancer reporting protocols in this discipline. She is involved in collaborative research with both the MHW and the breast and respiratory services at Austin Health and has a strong interest in quality assurance, risk management, governance, ethics, teaching and patient-centred care.
Naveena Singh studied Medicine at the University of Delhi, India. She trained in Pathology at the Postgraduate Intitute of Medical Education and Research, Chandigarh, India, and at Barts and the London, London, UK. She is a consultant pathologist at Barts Health NHS Trust and Honorary Professor at Barts and the London School of Medicine and Dentistry, Queen Mary University of London. She has a specialist interest in gynaecological pathology and combines a heavy clinical workload with teaching and collaborative research. She is part of the trial management groups of several ongoing clinical trials in gynaecological cancer. She is a series editor of a textbook series on gynaecological pathology, co-author of a textbook in Cytopathology, and invited author of many review articles, chapters, Royal College of Pathologists (RCPath) datasets, and several guideline documents. She is a co-author in numerous peer-reviewed original research papers. She is a member of the RCPath Working Group on Cancer Services. She has been the meetings secretary (2008-2013) and President (2016-2019) of the British Association of Gynaecological Pathologists.
Marsali obtained FRCPA in 2002 and worked at Melbourne Pathology until 2006, when she joined Austin Pathology, with a focus on providing expertise in gynaecological pathology to the Mercy Hospital For Women.
She has a special interest in oncological pathology, particularly in the areas of gynaecological, head and neck, and lung. She has a strong interest in both gynaecological and non-gynae cytology and is an Australian Society of Cytology examiner, and a member of the Cytopathology Advisory Committee for the Royal College of Pathologists of Australasia (RCPA). She is involved in teaching, anatomical pathology related research, development of structured reporting and quality assurance. Marsali is a member and a protocol co-author for the RCPA Gynaecological Cancer Committee, overseeing structured reporting protocols for gynaecological malignancies, and a member of the International Collaboration for Cancer Reporting.
Dr Joo Shin is a medical graduate of University of Queensland. His training included initially Chemical Pathology and then Anatomical Pathology, which was mostly at Royal Prince Alfred and Liverpool Hospitals. He was awarded his FRCPA in 2009. He combined his training with a PhD on the ‘Predictive markers of radiotherapy response in rectal cancers’, which was awarded from University of Sydney in 2011.
He is a Senior Staff Specialist at Royal Prince Alfred Hospital with primary subspecialty interests in Gastrointestinal Tract, Liver and Breast pathology. He regularly presents at the Multidisciplinary team meetings in Neuroendocrine and Upper GIT, Colorectal, Gastroenterology and Breast Surgery Units at RPA/Chris O’Brien Lifehouse. He joined our department in 2017and was previously a specialist at Liverpool Hospital and a Senior Lecturer at Western Sydney University, involved in Pathology teaching and curriculum design at the then its new medical school. There, he also co-supervised successful competition of multiple MBBS Honours, Masters and PhD students.
His research output to date has followed on from his PhD and has concentrated on biomarkers of treatment response, disease progression and prognosis in mainly colorectal, and also breast cancers.
Joo has amassed a box full of cheap plastic sporting trophies for coming runner up, third or making up the numbers in multiple obscure suburban and school competitions, which are proudly stuffed in his garage.
Rondell P. Graham, M.B.B.S., studies the molecular genetics of liver tumors with a focus on biomarkers for diagnosis, treatment and classification of tumors. His work seeks to understand how liver tumors develop and progress. The long-term intent is to identify targets that define specific subtypes of liver tumors and also targets that can be treated with rational approaches to improve the outcome of patients affected by liver tumors.
Dr. Graham works with a team of investigators using a combination of traditional and novel histologic, molecular and proteomic approaches. This collaborative effort evaluates liver tumors, including fibrolamellar carcinoma, hepatocellular carcinoma and hepatocellular adenomas, in order to refine the understanding and classification of liver tumors.
Focus areas
Dr. Sylvia Asa, Clinician-Scientist Endocrine Pathologist, studies endocrine tumors to improve diagnosis and identify targets for therapy. Appointed to the Faculty of Medicine at University of Toronto in 1985, she was promoted to Professor in 1998. In 2019, she joined Case Western Reserve University in Cleveland, Ohio. Heading the largest academic pathology department in Canada at UHN in 2000-2015, she made innovative changes, emphasizing subspecialization, biobanking and digital pathology.
Dr John Turchini is a graduate of the University of Sydney. As a medical student, he was inspired to train in histopathology after a term at Concord Repatriation General Hospital. After practising in clinical medicine at Hornsby and Manly Hospitals, he trained in histopathology at Royal North Shore Hospital, with terms at Concord Repatriation General Hospital, the Department of Forensic Medicine and the Department of Neuropathology at Royal Prince Alfred Hospital. On attaining fellowship, he worked as a consultant histopathologist at Royal North Shore Hospital before commencing at Douglass Hanly Moir Pathology. Dr Turchini has a keen interest in research and has been involved in the publication of many peer-reviewed journal articles. He is passionate about pathology-based medical education and has created educational modules for the Royal College of Pathologists, Australasia, in addition to currently completing a PhD in medical education. Dr Turchini is a clinical lecturer at the University of Sydney, a lecturer at the University of Technology, Sydney, and the convenor of the endocrine meeting of the Australasian division of the International Academy of Pathology.
Jane is Dean of the College of Health and Medicine at the Australian National University (ANU) and also Professor of Pathology at ANU Medical School. She is a Senior Staff Specialist at ACT Pathology, The Canberra Hospital where she is in charge of the immunohistochemistry laboratory. Jane was born and raised in Sydney Australia. She is a medical graduate of Sydney University. After completing her PhD at the John Curtin School of Medical Research at the ANU she entered speciality training in Anatomical Pathology. She is a Fellow of the Royal College of Pathologists of Australasia (RCPA) in Anatomical Pathology, Oral Pathology and is a founding Fellow of the Faculty of Science of her College.
Jane enjoys teaching and is an active researcher with particular interests in immunohistochemistry, placental, breast and oral pathology.
Professor John Nicholls is a Clinical Professor in Pathology at the University of Hong Kong. He commenced medical studies at the University of Adelaide, South Australia in 1977 and graduated in 1983. He commenced postgraduate training in pathology at the Institute of Medical and Veterinary Sciences, the Queen Elizabeth Hospital and The Adelaide Children’s Hospital. In 1988 he moved to Hong Kong as a Lecturer in Pathology at the University of Hong Kong where in addition to clinical and teaching duties commenced research into the relationship of viruses with the respiratory tract. His publications were focused on the role of Epstein-Barr Virus in nasopharyngeal carcinoma, a common tumour in the Guangdong region.
In 1997, following the first outbreak of H5N1 influenza in humans, he commenced collaboration with the Department of Microbiology to study the pathological effects of avian influenza viruses in the respiratory tract. In 2003 he was a key member of the research team at the University of Hong Kong which isolated and characterized the novel SARS coronavirus which was associated with the global outbreak of 2003.
His work on SARS and avian influenza has been published in prestigious journals such as Lancet, PLOS Medicine and Nature Medicine as listed in part of his selected biography. His current investigative work is looking at the viral binding sites in the respiratory tract and determining susceptibility to avian influenza in humans and other animals. Together with staff from the School of Public Health he has established a lung and bronchial ex vivo culture system to investigate tropism and pathogenesis of emerging viral infections, as well as potential novel antiviral agents such as DAS181 in these systems. In 2009 he was awarded a Croucher Senior Medical Fellowship to work on novel therapeutic strategies for influenza.
Dr Van Es is a medical graduate from the University of Sydney (1991) and is a Fellow of the Royal College of Pathologists of Australasia (Anatomical Pathology). After her intern and RMO years at Royal Prince Alfred Hospital, she spent 12 months working in palliative care medicine and general practice, followed by several years working in Sexual Health Medicine. After this Dr Van Es pursued postgraduate specialist training in Anatomical Pathology/Cytopathology. Dr Van Es obtained her Fellowship with the Royal College of Pathologists of Australasia (Anatomical Pathology/Cytopathology) in 2003. She worked as a consultant dermatopathologist for several years and also held a fractional postgraduate Fellowship position in Melanoma Pathology in 2005.
Dr Van Es has worked as a lecturer in Pathology with the School of Medical Sciences (SOMS), UNSW Medicine, since 2008. She received the SOMS contribution to the student experience award in 2010. In 2013 Dr Van Es was recipient of the Pathology Day Prize from the RCPA (Royal College of Pathologists of Australasia) for the teaching and quizzes organised at UNSW for Pathology Day 2013. For International Pathology Day in 2014, Dr Van Es authored the RCPA Pathology Day Quiz (a complex quiz on the selection and interpretation of pathology tests and their clinical application) for medical students and Pathology trainees throughout Australia. In 2019, she was awarded a Fellowship of the Faculty of Science for scientific achievement by The Royal College of Pathologists of Australasia (RCPA).
To date, Dr Van Es is responsible for the creation of over 250 histopathology and cytopathology whole slide images, which are hosted on the BEST (Biomedical Education, Skills and Training) Network virtual slide repository. This virtual slide repository is a teaching resource that is used by institutions throughout Australia. Dr Van Es also has accumulated experience authoring VMATs (virtual microscopy adaptive tutorials). These virtual slides and VMATs have formed the basis of Dr Van Es' research and teaching both for UNSW and external pathology institutions (Royal College of Pathologists of Australasia).
Dr Van Es obtained her PhD in Digital Pathology in 2015. Since this time, in addition to her work at UNSW, she has continued to collaborate on projects with the Royal College of Pathologists of Australasia (RCPA) and the Royal College of Pathologists of Australasia Quality Assurance Programs (RCPAQAP) in digital pathology and online education in histopathology and cytopathology.
Dr. Bychkov is the Director of Digital Pathology at Kameda Medical Center, Japan, and Visiting Associate Professor at Nagasaki University, Japan. Dr. Bychkov is originally from Russia, where he obtained his MD and practiced in anatomic pathology. Currently, he is tasked with overseeing digital pathology initiatives in Japan. His research interests are digital pathology and thyroid pathology. Dr. Bychkov is an associate editor for PathologyOutlines and several journals (JPTM, PLOS One, etc.) He has published extensively and has authored over 80 journal articles and book chapters. He regularly presents at various conferences and pathology meetings, including top-ranked events (USCAP, IAP, IAC, and ECP.)
Dr Kais Kasem is an Associate Professor in clinical pathology at University of Melbourne and leads the pathology discipline teaching for the Doctor of Medicine program. Kais is a surgical pathologist who trained in Queensland hospitals and obtained the Fellowship of the Royal College of Pathologists in 2016. He holds a PhD degree in molecular pathology of cancer and has discovered the role of a new tumour suppressor gene in colorectal cancer. He has an interest in skin and gastrointestinal pathology, as well as gynaecological cytology and histopathology. He is an author on numerous peer reviewed publications in surgical pathology, molecular pathology and medical education.
Prof Martin Hale is a specialist anatomical pathologist who has spent his entire career working in the public sector both in Zimbabwe and South Africa. He has extensive experience in diseases that are prevalent in sub-Saharan Africa, particularly infectious disease and malignancy, inclusive of HIV. In particular he has an interest in HIV related malignancy, and the interplay between co-infection with HIV and other infections. Other interests include the changing epidemiology of disease as the local lifestyle of the population changes over time.
Prof Hale is fully committed to undergraduate and postgraduate training, recognising that good undergraduate education is a prerequisite to developing good postgraduate programmes. His educational initiatives have included improvement of postgraduate training in sub-Saharan Africa developed through the International Academy of Pathology. A significant milestone was his successful bid preparation and subsequent hosting of the international Congress of the international Academy of pathology in Cape Town, South Africa in 2012, a first for the African continent. The objective of this meeting was to enhance pathology education on the African continent. This was an overwhelming success with over 330 delegates from Africa attending, 150 of them being supported by bursaries sourced through the IAP.
Prof Hale has been involved with a number of collaborative research projects over the years including projects that have been funded by prestigious funding agencies. He recognises that postgraduate training cannot be complete without a research component.
Associate Professor Raghwa Sharma graduated from the University of Fiji in the 90s and trained in Sydney to be a senior staff specialist. But he never lost sight of our Pacific Islander neighbours. For the last 15 years he has returned to the region believing expert training could make a real difference to helping diagnose cancer which has been on the rise in the area for some time. “In 2002 I travelled to Suva to help the only pathologist there diagnose cancer,” said Associate Professor Sharma, NSW Health Pathology Senior Staff Specialist, Westmead. “This registrar had no training and could learn only by watching me. More difficult cases were referred back to our Westmead lab, but I knew the long-term solution was post graduate pathology training.” With help from our team of experts at Westmead and the Royal College of Pathologists of Australasia, Prof Sharma gained support from the Fijian Health Minister and the University of Fiji to develop a Master of Pathology that began in 2011. The four-year course covers microbiology, forensic pathology, haematology and chemical pathology with students choosing a speciality in the last two years of the program. Since the program began, a number of our pathologists have joined Prof Sharma volunteering their time to teach in the program. Students also have the opportunity to come to Australia and complete placements in our labs.
Dr Louise Jackett completed undergraduate medical studies at the University of Tasmania and was awarded Bachelor of Medical Science and Bachelor of Medicine and Surgery with honours in 2007. Louise undertook specialist training in Anatomical Pathology in Victoria and became a Fellow of the Royal College of Pathologists of Australasia in 2015. Following this, she undertook a fellowship in melanoma pathology at Melanoma Institute Australia and Royal Prince Alfred Hospital in Sydney under the guidance of Prof Richard Scolyer. She was subsequently appointed as a consultant Anatomical Pathologist at Royal Prince Alfred Hospital. Louise has received world-class training in melanocytic lesions through extensive consultation practice and collaborative research, and has contributed in this field to several international conferences as an invited speaker. She has held honourary research affiliation with the School of Medicine at University of Sydney and has been actively involved in teaching medical students and junior doctors. Louise commenced at Austin Pathology in 2018 and continues to develop her interests in melanoma, dermatopathology and liver pathology.
Aleodor (Doru) Andea, MD, MBA, is a Professor of Pathology and Dermatology and Director of the Dermatopathology Fellowship at the University of Michigan in Ann Arbor, MI. Dr. Andea's areas of expertise are Dermatopathology and Molecular Pathology. Dr. Andea received his MD from "Victor Babes" University of Medicine, Timisoara, Romania and completed an Anatomic and Clinical Pathology Residency at Wayne State University in Detroit, Michigan. This was followed by fellowships in Dermatopathology at Medical University of South Carolina, Charleston, SC and Oncologic Pathology and Molecular Pathology at Memorial Sloan-Kettering Cancer Center, New York, NY. After completing his training Dr Andea joined the faculty of the Department of Pathology at the University of Alabama at Birmingham (UAB) where he served as Director of the Dermatopathology Fellowship program, Medical Director of the In-situ Hybridization Laboratory and as Dermatopathology Section Head. In 2009 Dr. Andea received the "Leonard H. Robinson" Award for Excellence in Resident Education in Anatomic Pathology. At UAB Dr. Andea developed a research interest in the molecular biology of melanocytic neoplasms and precision molecular diagnostic tests for histologically ambiguous melanocytic tumors. While at UAB, Dr. Andea earned a Master of Business Administration degree from UAB School of Business.
At the University of Michigan Dr. Andea has established and is leading the Molecular Dermatopathology Research Laboratory which functions as a dermatopathology core facility for skin cancer research and the Dermatopathology Molecular Diagnostics Laboratory providing clinical testing for melanocytic tumors. Dr Andea has a particular interest in developing and improving ancillary molecular tests to help classify and predict prognosis in histologically ambiguous melanocytic tumors. As a side hobby he enjoys playing with digital pathology tools and is interested in exploring the potential for implementation of virtual pathology into clinical work. He was invited to deliver numerous national and international presentations on a variety of dermatopathology topics, with a focus on molecular diagnostic tools for melanocytic tumors and digital pathology. Dr. Andea is the author of over 60 peer-reviewed publications, over 100 abstracts and one book chapter, mainly in the field of dermatopathology. Outside of pathology he enjoys skiing and swimming.
Dr Oana Crainic graduated from medicine at the University of Medicine and Pharmacy Iuliu Hatieganu, Cluj Napoca, Romania. After spending eight years in clinical medicine, including dermatology, in both Romania and New Zealand, she completed her postgraduate training in anatomical pathology in Christchurch, New Zealand, and the Melanoma Institute of Australia. She obtained Fellowship from the Royal College of Pathologists of Australasia in 2013. Dr Crainic developed a special interest in dermatopathology with emphasis in melanocytic pathology and completed a Fellowship at the Melanoma Institute of Australia. She was a Staff Specialist in the Department of Tissue Pathology and Diagnostic Oncology at Royal Prince Alfred Hospital for two years, before joining Douglass Hanly Moir Pathology in May 2015. In 2016, she received International Board Certification in Dermatopathology under the auspices of the International Committee for Dermatopathology (ICDP/UEMS).
Dr Crainic has a broad range of interests in surgical pathology, with special interests in dermatopathology, haematolymphoid pathology and gynaecological pathology, as well as cytopathology. She has expertise in biopsies for alopecia and direct immunofluorescence. She is also involved in a variety of teaching activities for medical students, pathology and dermatology registrars.
A/Prof Elizabeth Salisbury
Clinical Director Anatomical Pathology
Westmead Hospital
Elizabeth.Salisbury@health.nsw.gov.au
Professor Mary Sheppard is a cardiac pathologist with a national and international reputation.
She is the director of unit that undertakes examination of the heart in cases of sudden cardiac death in UK. She has established a national cardiac pathology database, with funding from UK charity Cardiac Risk in the Young (CRY), which now has over 7,000 cases on file. The unit has built up a large biobank of heart tissue and genetic material for research.
Professor Sheppard's main area of interest are the cardiac conditions that cause sudden death in young people which are mainly inherited, such as sudden arrhythmic death, cardiomyopathies including dilated cardiomyopathy, hypertrophic cardiomyopathy, arrhythmogenic cardiomyopathy and idiopathic hypertrophy .
She works closely with cardiac genetics to examine phenotype/genotype expression. She also has an interest in cardiac development, anatomy and congenital heart disease.
The unit is a multiuser facility using histological techniques for diagnosis of heart disease. Scanning techniques are used to quantify changes which are diagnostic of specific cardiac diseases. The unit uses quantification and immunocytochemistry with a digital scanner for image analysis.
Professor Sheppard’s main focus is on the pathological diagnosis of sudden cardiac death. She collaborates with cardiologists who screen the families for these cardiac conditions throughout the UK. She works with scientists, as well as clinicians in understanding the pathophysiology underlying these conditions.
Dr Vanathi Sivasubramaniam MBBS (U Qld), FRCPA completed her medical degree at the University of Queensland in 1994, and after extensive clinical medical experience with focus on emergency medicine and anaesthetics, she completed her Anatomical Pathology training in April 2011. Her training was predominantly based at St. Vincent’s Hospital (Sydney) with rotations to Liverpool Hospital, Prince of Wales Hospital and the Department of Forensic Medicine, Glebe, and included a rotation to the Mayo Clinic in Arizona where she completed the Geraldine Colby Zeiler Fellowship in Lung and Cytopathology. She was appointed as a part-time Staff Specialist at St. Vincent’s in May 2011. She is actively involved in undergraduate teaching for UNSW, as well as in pathology registrar training and is a member of the International Academy of Pathology, the Pulmonary Pathology Society, the Society for Cardiovascular Pathology and the Australian Society of Cytology.
She has special interests in lung and cardiovascular cytopathology pathology as well as gastrointestinal, neurosurgical, renal, soft tissue and head and neck pathology.
Dr Tan Puay Hoon is Senior Consultant Histopathologist and Chairman, Division of Pathology, Singapore General Hospital, Singapore. She has active interests in breast, urologic and renal pathology, and was a Volume Editor of the 2012 WHO Classification of Tumours of the Breast. She sits on the Editorial Boards of Modern Pathology, Breast Cancer Research, Journal of Clinical Pathology, Pathology, Seminars in Diagnostic Pathology, and Analytical and Quantitative Cytology and Histology. She is Associate Editor of Histopathology and the Singapore Medical Journal. Apart from a busy service largely focused on subspecialty surgical signouts, she and her collaborators are recipients of several research grants related to translational studies of breast and prostate cancer. She is author of more than 400 publications, and participates regularly in regional and international meetings.
Dr Tan’s research interests in breast pathology centre around the classification of breast fibroepithelial lesions and their molecular pathogenesis, triple negative breast cancers, and ductal carcinoma in situ. In urologic pathology, she is engaged in prostate and renal cancer studies and is a contributor to the 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs.
She is the immediate Past-President of the International Society of Breast Pathology, and was Councillor for Asia of the International Society of Urological Pathology (2009 – 2015).
Associate Professor Wendy Raymond qualified in Medicine at the University of Adelaide Medical School in 1986 and went on to specialise in anatomical pathology, gaining her research degree (MD) on “Prognostic markers in breast cancer” in 1991, and her Fellowship of the Royal College of Pathologists of Australasia in 1992. Her pathology training involved appointments in Adelaide and in Manchester, UK, before she returned to South Australia as a Consultant Histopathologist at Flinders Medical Centre and Senior Lecturer at Flinders University of South Australia.
She held a Visiting Consultant appointment as Cytopathologist at BreastScreen SA (1998-2015), and worked part-time as a Specialist Pathologist for Drs King and Mower Pathology and subsequently Healthscope Pathology, from 2005-2014.
She also continued as a part-time specialist at Flinders Medical Centre (SA Pathology) and, since 2010, has held the academic title of Associate Professor in the School of Medicine, Flinders University. A/Prof Raymond was Senior Pathologist, Head of Unit, at BreastScreen SA 2012-2015. In 2012, she was awarded Fellowship of the International Academy of Cytology. She has held roles of Anatomical Pathology examiner and Cancer Services and Cytopathology Advisory Committee member for The Royal College of Pathologists of Australasia. She is a Past President of the Australasian Society of Breast Disease and of the Australian Society of Cytology. She has been actively involved in national breast cancer reporting guidelines, implementation of HER 2 assessment and quality assurance committees and is currently Chair of the Breast Pathology Quality Assurance Committee.
A/Prof Raymond has a particular interest and expertise in breast and endocrine histopathology, fine needle aspiration and general cytopathology, and has published widely in these areas, including co-editing the recent IAC Yokohama System for Reporting Breast Fine needle aspiration biopsy Cytopathology.
Dr. Jason Hornick received a BA from Amherst College and an MD/PhD from the University of Southern California. He trained as a resident in Anatomic Pathology and pursued subspecialty fellowships in soft tissue pathology and gastrointestinal pathology at Brigham and Women’s Hospital, where he is now the Director of Surgical Pathology and Director of the Immunohistochemistry Laboratory. He is an Associate Professor of Pathology at Harvard Medical School and a consultant at the Dana Farber Cancer Institute.
Dr. Hornick is Chair of the USCAP Abstract Review Board and Assignment Committee and Chair of the CAP Immunohistochemistry Committee. Dr. Hornick was a member of the 2012 consensus and editorial working group for the WHO Classification of Tumors of Soft Tissue and Bone. He is currently a member of the Soft Tissue Sarcoma Expert Panel for the AJCC and the Sarcoma Analysis Working Group for The Cancer Genome Atlas (TCGA). He also serves on the Test Development and Advisory Committee for Anatomic Pathology for the American Board of Pathology.
Dr. Hornick serves on many editorial boards, including the American Journal of Surgical Pathology and Modern Pathology. He is a Regional Editor for Histopathology, an Associate Editor for Advances in Anatomic Pathology, and the Consulting Editor for Surgical Pathology Clinics. Dr. Hornick has published over 280 original papers, review articles, and book chapters and has edited the textbook Practical Soft Tissue Pathology: A Diagnostic Approach. He is an Associate Editor for Sternberg’s Diagnostic Surgical Pathology.
Dr. Hornick received the 2012 Arthur Purdy Stout Society of Surgical Pathologists Annual Prize and the 2014 Jack Yardley Investigator Award from the Gastrointestinal Pathology Society. He teaches national and international courses on the diagnosis of soft tissue tumors, gastrointestinal pathology, and diagnostic immunohistochemistry.
Dr Daniel Wong is a Consultant Pathologist at PathWest, the State laboratory for Western Australia and Senior Clinical Lecturer in the School of Medicine at the University of Western Australia. He is subspecialised in soft tissue and bone pathology and is one of several pathologists working as part of the Western Australia State Sarcoma Service as well as the Chairperson of the Australasian Soft Tissue Tumour Registry. He has authored a number of peer-reviewed publications and textbook chapters, including in the WHO Classification of Tumours. He has presented at mutliple local, national and international conferences and is the current Convenor of the Bone and Soft Tissue Club in the Australasian Division of the International Academy of Pathology.
Dr. Liza Boucher is rejoining the Provincial Forensic pathology Unit as a staff forensic pathologist in November 2018, after working as a forensic pathologist at the Laboratoire de sciences judiciaires et de médecine légale in Montreal (LSJML) for just over five years. Liza obtained her medical degree and Doctorate in Medicine at the University of Montreal in 2004, followed by three years of training in General Surgery and an Anatomical Pathology residency at Laval University. She completed her residency training in Forensic Pathology at the University of Toronto/Provincial Forensic Pathology Unit program in 2012. Liza is also a Fellow of the Royal College of Physicians and Surgeons of Canada in Anatomical and Forensic Pathology.ine, Griffith University, Gold Coast
A/Chief Forensic Pathologist, Eminent Staff Specialist Forensic Pathology, Associate Professor in School of Medicine, Griffith University, Gold Coast
Associate Professor Tan Kong Bing is a medical graduate of the National University of Singapore (NUS), obtaining his MBBS in 1995. After undergoing stints as a house- and medical officer in various clinical departments, he underwent residency training in pathology in NUS from 1999-2004. He attained the MRCPath (UK) and FRCPA in 2004 and continues his work in the pathology department at NUS as a specialist pathologist and an Associate Professor.
His subspecialty interests are in muscle and skin pathology. He underwent clinical fellowship training in the two disciplines at the University of Sydney, the Royal Prince Alfred Hospital (Sydney) and the Skin and Cancer Foundation Australia in 2006-2007. He was certified with a Diploma in Dermatopathology (ICDP-UEMS) since 2008. Apart from the afore-mentioned subspecialties, A/Prof Tan also handles a regular pathologist-clinician load of general histopathology and cytopathology reporting.
A/Prof Tan partakes in some Dermatopathology research and collaboration. To date, he has 41 peer-reviewed publications/ book chapters, 31 conference presentations and 3 research poster prizes. In medical education, he helps coordinate and deliver pathology teaching to the medical, pharmacy and dentistry undergraduates and was recognised with a faculty teaching excellence award in 2006/2007. He also conducts postgraduate dermatopathology teaching to pathology and dermatology Residents.
Professor Wendy Cooper is a senior staff specialist in Tissue Pathology and Diagnostic Oncology at Royal Prince Alfred Hospital in Sydney, Anatomical Clinical Stream Lead for NSW Health Pathology, a Clinical Professor at the University of Sydney and a Conjoint Professor at the University of Western Sydney. She graduated from Medicine at the University of Sydney with First Class Honours in 1998. She also received a Bachelor of Science (Med) with First Class Honours in 1996.
She obtained her Fellowship from the Royal Australasian College of Pathologists in 2004 and in 2008 completed a PhD from the University of Sydney titled “Molecular markers of prognosis in early stage non-small cell lung cancer” for which she received the prestigious Peter Bancroft Prize.
She has extensive experience in diagnostic and molecular pathology with special interest in pulmonary pathology and molecular biomarkers. Wendy is the Chair of RCPA Cancer Services Advisory Committee, Chair of the Pathology Committee of the International Association for the Study of Lung Cancer, Thoracic series champion for the International Collaboration on Cancer Reporting and a member of the Expert Panel for the international CAP/IASLC/AMP Lung Cancer Biomarker Guidelines. She has over 120 publications and was an editor and author of the new 5th edition of the WHO classification of Thoracic Tumours.
